Download:
pdf |
pdfSaving, Retrieving or Emailing your data can only be done with the full version of the Adobe Acrobat or the Adobe Approval and not with the free Adobe Reader.
Section
Retrieve Data
9a
Reset Form
VETERINARY ADVERSE DRUG REACTION,
LACK OF EFFECTIVENESS,
PRODUCT DEFECT REPORT
FOOD AND DRUG ADMINISTRATION
7500 Standish Place (HFV-210), Room N403
Rockville, MD 20855
Form Approved: OMB No. 0910-0284
Expiration Date: June 30, 2006
(Forward to address at left. Attach all correspondence that pertains to this reaction)
Public reporting burden for this collection of information is estimated to average 2 hour per response, including the time for reviewing instructions, searching existing data
sources, gathering and maintaining the data needed, and completing reviewing the collection of information. Send comments regarding this burden estimate or any other
aspect of this collection of information, including suggestions for reducing this burden to:
An agency may not conduct or sponsor, and a person is not required
Food and Drug Administration
to respond to, a collection of information unless it displays a currently
7500 Standish Place (HFV-210), Room N403
valid OMB control number.
Rockville, MD 20855
NOTE: This report is required by law (21 CFR 510.300). Failure to report can result in withdrawal of approval of the application.
1. REPORT SOURCE AND ADDRESS (Mfr., Distr.)
2a. DATE REPORT RECEIVED
3a. TYPE OF REPORT
3-day Alert
b. DATE SENT TO FDA
3b.
c.
4. NAME, ADDRESS AND PHONE NO. OF ATTENDING VETERINARIAN
(In confidence)
15-day Alert
Periodic Report
NUMBER OF DAYS BETWEEN 2a AND b:
Initial Report
Follow Up Report
Of (Give Date)
5. NAME OR CASE IDENTIFICATION OF OWNER
(In confidence)
Name:
Street Address:
City:
State:
ZIP:
Phone No. ( __ __ __ ) __ __ __ - __ __ __
6. TRADE NAME AND GENERIC NAME(S) OF ACTIVE INGREDIENT(S)
(Include dosage form and strength - Ex., tab, 500 mg.)
7a. NAME OF MANUFACTURER
8. LOT NUMBER(S)
10. DATE(S) OF ADMINISTRATION
b. NADA NO.
9. DOSAGE ADMINISTERED AND ROUTE
(Ex. 250 mg., q 12 h, p.o.)
11. ILLNESS/REASON FOR USE OF THIS DRUG
12. DRUG WAS ADMINISTERED BY
OWNER, OTHER
VETERINARIAN, STAFF
NUMBER OF ANIMALS IN THIS INCIDENT
13.
a. TREATED WITH DRUG
b. REACTED
14.
a. SPECIES
c. DIED
REACTING ANIMALS
b. BREED
d. WEIGHT
c. AGE
15. CONCOMITANT MEDICAL PROBLEMS
e. SEX
FEMALE
16. OVERALL STATE OF HEALTH AT TIME OF REACTION
GOOD
FAIR
POOR
CRITICAL
18.
MALE
PREGNANT
NEUTERED
17. DID ANY NEW ILLNESS DEVELOP OR DID INITIAL DIAGNOSIS CHANGE AFTER
SUSPECT DRUG STARTED?
YES (Explain)
NO
CONCOMITANT DRUGS ADMINISTERED
NAME OF DRUG
ROUTE
DOSAGE REGIMEN
DATE(S) OF ADMINISTRATION
FOR FDA USE ONLY
COMMENT
1.
2.
3.
4.
5.
6.
T.
D
NAI
PR
AI
PO
AP
R
AL
NC
I.L.
CR
CONT
FORM FDA 1932 (9/03)
PSC Media Arts (301) 443-1090
Save Data
Next Page
EF
Previous Page
REACTION DATA
19. DESCRIBE SUSPECTED ADVERSE REACTION: INCLUDE ALL SIGNS, RESULTS OF PERTINENT LAB TESTS, NECROPSY RESULTS, POSSIBLE
CONTRIBUTING FACTORS, ETC. ALSO, INCLUDE IN THIS SECTION PRODUCT INEFFECTIVENESS AND PRODUCT DEFECTS SUCH AS CRACKED
TABLETS, CLOUDY SOLUTION, ETC.
20a. ATTENDING VETERINARIAN’S LEVEL OF SUSPICION THAT DRUG
CAUSED REACTION
HIGH
MEDIUM
LOW
20b. WAS THERE EXTRA LABEL USE (ELU) INVOLVED?
NO ATTENDING VET.
NO
YES (Explain)
21. LENGTH OF TIME BETWEEN LAST ADMINISTRATION OF SUSPECT DRUG AND
ONSET OF REACT
22. DATE OF ONSET
(Mo., day, yr.)
23. DURATION OF REACTION
(Hrs., days, etc.)
24. WAS THE ADVERSE REACTION TREATED?
25. OUTCOME OF REACTION TO DATE
DIED (Give date)
NO
YES (Describe treatment)
REMAINS UNDER TREATMENT
ALIVE WITH SEQUELAE
RECOVERED
UNKNOWN
26. WHEN REACTION APPEARED, TREATMENT WITH SUSPECT
DRUG:
HAD ALREADY BEEN COMPLETED
CONTINUED
DISCONTINUED DUE TO THE REACTION
DISCONTINUED, REPLACE WITH ANOTHER DRUG
DISCONTINUED, REINTRODUCED LATER
STOPPED
AND THE
REACTION
RECURRED
OTHER (Explain)
CONTINUED AT ALTERED DOSE
OTHER (Explain)
27. HAD ANIMAL(S) BEEN PREVIOUSLY EXPOSED TO THIS DRUG?
NO
YES
UNKNOWN
NO
YES
UNKNOWN
NO
YES
UNKNOWN
28. DID ANIMAL(S) PREVIOUSLY REACT TO THIS DRUG?
29. HAD ANIMAL(S) PREVIOUSLY REACTED TO OTHER DRUGS?
(If yes, give drug(s) and reaction if known)
30. HAS THE ATTENDING VETERINARIAN SEEN SIMILAR REACTIONS TO THIS DRUG IN ANY OTHER ANIMALS?
NO
YES (Describe treatment)
31. NAME AND TITLE OF INDIVIDUAL RESPONSIBLE FOR ACCURACY
OF REPORTED INFORMATION (Type or print)
32. SIGNATURE OF INDIVIDUAL RESPONSIBLE FOR ACCURACY OF REPORTED
INFORMATION
FORM FDA 1932 (9/03)
Save Data
Print
Email Form
File Type | application/pdf |
File Modified | 2003-12-24 |
File Created | 2003-10-20 |